You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Oral Cavity Cancer

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pneumonia, Pneumococcal, Diabetes, Breast Cancer Trial (Text message nudge)

Not yet recruiting
  • Pneumonia, Pneumococcal
  • +3 more
  • Text message nudge
  • (no location specified)
Apr 4, 2023

Evaluation of MCM5 in Postmenopausal Bleeding Patients

Recruiting
  • Endometrial Cancer
  • MCM5 ELISA
  • Manchester, United Kingdom
    Saint Mary's Hospital, Central Manchester NHS Foundation Trust
Jan 30, 2023

Lung Cancer, Anaplastic Lymphoma Kinase Gene Translocation, ROS1 Rearrangement Trial in Boston (Lorlatinib, Crizotinib,

Recruiting
  • Lung Cancer
  • +6 more
  • Boston, Massachusetts
  • +1 more
Mar 7, 2021

Pediatric Kidney Disease Trial in Mansoura (SWL, SWL and ODT)

Completed
  • Pediatric Kidney Disease
  • SWL
  • SWL and ODT
  • Mansoura, Outside U.S./Canada, Egypt
    Urology and Nephrology Center
May 31, 2023

Malignant Tumor Trial in Houston (Isopropyl Alcohol, Placebo, Questionnaire Administration)

Not yet recruiting
  • Malignant Neoplasm
  • Isopropyl Alcohol
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Cystic Fibrosis Trial in Richmond (Oral Aztreonam, Nasal Aztreonam, Nasal Placebo)

Terminated
Has Results
  • Cystic Fibrosis
  • Oral Aztreonam
  • +2 more
  • Richmond, Virginia
    Children's Hospital of Richmond at VCU
Jan 11, 2021

Recurrent Endometrial Serous Adenocarcinoma Trial in Columbus (procedure, biological, drug)

Not yet recruiting
  • Recurrent Endometrial Serous Adenocarcinoma
  • Biospecimen Collection
  • +4 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
May 12, 2023

Locally Advanced Rectal Cancer Trial in Beijing (Long-course chemoradiation, with Tislelizumab (PD-1 inhibitor), Long-course

Recruiting
  • Locally Advanced Rectal Cancer
  • Long-course chemoradiation, with Tislelizumab (PD-1 inhibitor)
  • Long-course chemoradiation, without Tislelizumab (PD-1 inhibitor)
  • Beijing, Beijing, China
    Beijing Friendship Hospital, Capital Medical University
Apr 25, 2023

Lung Cancer, Small-cell Lung Cancer, Non Small Cell Lung Cancer Trial in Philadelphia (Carboplatin, Pemetrexed, Paclitaxel)

Recruiting
  • Lung Cancer
  • +2 more
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Mar 24, 2023

Kidney Failure, Chronic Trial in France (No oral anticoagulation, Oral anticoagulation with vitamin K antagonists)

Recruiting
  • Kidney Failure, Chronic
  • No oral anticoagulation
  • Oral anticoagulation with vitamin K antagonists
  • Amiens, France
  • +24 more
Sep 13, 2021

Genetic Predisposition Trial in Philadelphia (Digital Care Plans)

Not yet recruiting
  • Genetic Predisposition
  • Digital Care Plans
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Feb 8, 2023

Heart Failure Trial (Bis-Hexanoyl (R)-1,3-Butanediol, Placebo)

Not yet recruiting
  • Heart Failure
  • Bis-Hexanoyl (R)-1,3-Butanediol
  • Placebo
  • (no location specified)
Mar 2, 2023

Cancer, Post-cancer, Hematology Trial in Pierre-Bénite (JUMP group)

Not yet recruiting
  • Cancer
  • +2 more
  • JUMP group
  • Pierre-Bénite, France
    Hôpital Lyon Sud, rhumatologie
Aug 18, 2023

Prognostic Understanding in ESC (ProgESC Study)

Not yet recruiting
  • Advanced Cancer
    • (no location specified)
    Oct 4, 2023

    Breast Tumor Trial in New York (RealRisks, BNAV)

    Active, not recruiting
    • Breast Neoplasm
    • RealRisks
    • BNAV
    • New York, New York
      Columbia University Medical Center
    Aug 16, 2022

    Gastro-Intestinal Disorder Trial in Zagazig (Propofol Injection [Diprivan], Dexmedetomidine [Precedex], Palatable Lidocaine

    Completed
    • Gastro-Intestinal Disorder
    • Propofol Injection [Diprivan]
    • +2 more
    • Zagazig, Elsharqya, Egypt
      Faculty of medicine, zagazig university
    Aug 5, 2020

    Prostate Carcinoma Trial in United States (Darolutamide, Goserelin Acetate, Leuprolide Acetate)

    Recruiting
    • Prostate Carcinoma
    • Duarte, California
    • +107 more
    Jul 26, 2022

    Oxidative Stress and Mitochondrial TERT in Papillary Thyroid

    Recruiting
    • Papillary Thyroid Cancer
      • Milan, Italy
        Istituto Auxologico Italiano
      Mar 2, 2023

      Triple-Negative Breast Cancer Trial in Shanghai (Trastuzumab Deruxtecan)

      Not yet recruiting
      • Triple-Negative Breast Cancer
      • Trastuzumab Deruxtecan
      • Shanghai, Shanghai, China
        Breast cancer institute of Fudan University Cancer Hospital
      Jul 12, 2023

      Acquisition of Blood and Tumor Tissue Samples From

      Recruiting
      • Non-GI Cancers
      • +2 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 28, 2023

        Late Subclinical Cardiovascular Disease in Testicular Cancer

        Recruiting
        • Testicular Cancer
        • +7 more
        • Lipid profile
        • +2 more
        • Indianapolis, Indiana
          Indiana University
        Nov 7, 2022

        Sleep Wake Disorders, Sleep Disorders, Circadian Rhythm, Chronobiology Disorders Trial in United States (Tasimelteon, Placebo)

        Recruiting
        • Sleep Wake Disorders
        • +2 more
        • Los Angeles, California
        • +14 more
        Jan 12, 2022

        Cytomegalovirus Retinitis, HIV, Gastrointestinal Diseases Trial in United States (Ganciclovir)

        Completed
        • Cytomegalovirus Retinitis
        • +2 more
        • San Francisco, California
        • +16 more
        Oct 28, 2021

        T-Cell Lymphoma Relapsed, Adult T-Cell Leukemia (ATL), Peripheral T-Cell Lymphoma (PTCL) Trial run by the NCI (IL-15 plus,

        Completed
        Has Results
        • T-Cell Lymphoma Relapsed
        • +4 more
        • IL-15 plus
        • alemtuzumab
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Apr 27, 2022

        Advanced Malignancies, NSCLC, Ovarian Cancer Trial in Worldwide (Avelumab, Lorlatanib, Talazoparib)

        Recruiting
        • Advanced Malignancies
        • +4 more
        • Fayetteville, Arkansas
        • +61 more
        Jan 10, 2023